ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
821.94 | 188.70 | 147.13 | 463.16 | 295.28 | 273.71 | 227.89 | 238.36 | 1,209.45 | 1,469.23 |
Receivables |
450.53 | 483.68 | 528.48 | 474.64 | 614.29 | 575.95 | 704.91 | 837.28 | 939.49 | 1,036.23 |
Inventory |
268.32 | 268.70 | 349.64 | 416.92 | 457.03 | 743.91 | 998.01 | 822.25 | 927.71 | 945.81 |
Other current assets |
103.00 | 125.00 | 110.00 | 159.00 | 197.00 | 312.00 | 405.00 | — | — | 457.39 |
Total current assets |
1,644.00 | 1,065.72 | 1,145.37 | 1,523.46 | 1,574.76 | 1,931.48 | 2,367.83 | 2,357.72 | 3,505.61 | 4,324.74 |
Property, Plant, Equpment (Net) |
394.24 | 386.55 | 387.46 | 417.34 | 463.49 | 498.18 | 537.86 | 548.03 | 550.79 | 581.83 |
Goodwill and Intangible Assets (Total) |
1,326.67 | 1,284.13 | 2,378.40 | 2,338.49 | 2,320.48 | 2,282.39 | 3,322.64 | 3,327.96 | 3,511.54 | 3,362.31 |
Long Term Assets (Tax, Deferred) |
61.50 | 53.82 | 45.48 | 41.07 | 79.90 | 79.75 | 132.97 | 203.57 | 253.12 | 329.25 |
Long-term assets (Other) |
42.07 | 273.71 | 150.98 | 148.68 | 160.92 | 171.75 | 262.45 | 284.00 | 185.84 | 214.65 |
Total non-current assets |
1,824.48 | 1,998.21 | 2,962.32 | 3,063.92 | 3,153.37 | 3,164.38 | 4,383.88 | 4,514.68 | 4,668.79 | 4,641.21 |
Total Assets |
3,468.49 | 3,063.92 | 4,107.68 | 4,587.38 | 4,728.13 | 5,095.85 | 6,751.71 | 6,872.39 | 8,174.39 | 8,965.95 |
Notes Payable |
— | 11.47 | 11.99 | 11.99 | 12.00 | 9.92 | 9.90 | 9.90 | 9.90 | 259.95 |
Accounts Payable |
92.76 | 92.72 | 115.73 | 135.79 | 138.01 | 159.25 | 150.76 | 237.73 | 278.16 | 308.92 |
Accrued Expenses |
186.30 | 185.81 | 266.36 | 270.35 | 320.60 | 344.72 | 365.66 | 377.68 | 402.25 | 494.92 |
Current Part of Taxes to Pay |
29.15 | 160.43 | 73.25 | 64.76 | 307.96 | 44.89 | 72.22 | 107.52 | 132.27 | 98.11 |
Current Revenue (Deferred) |
51.92 | 60.83 | 88.67 | 98.62 | 109.61 | 108.67 | 138.07 | 152.55 | 166.03 | 162.91 |
Other current liabilities |
238.00 | 247.00 | 355.00 | 369.00 | 430.00 | 453.00 | 504.00 | — | — | 41.16 |
Total current liabilities |
360.13 | 511.25 | 555.99 | 602.76 | 911.77 | 689.30 | 758.53 | 910.66 | 1,019.12 | 1,395.11 |
Long Term Debt (Total) |
1,078.61 | 269.99 | 1,258.86 | 1,164.13 | 643.35 | 765.33 | 1,431.23 | 697.31 | 658.39 | 399.42 |
Non-current Revenue (Deferred) |
53.24 | 71.60 | 81.14 | 87.31 | 91.50 | 95.46 | 119.19 | 137.34 | 156.80 | 170.95 |
Long Term Tax Liability (Deferred) |
13.82 | 13.08 | 11.38 | 13.01 | 11.32 | 9.71 | 90.65 | 79.34 | 77.68 | 64.64 |
Non-current Liabilities (Other) |
2.43 | 139.03 | 128.11 | 121.26 | 69.74 | 54.86 | 105.35 | 42.26 | 141.52 | 213.03 |
Total non-current liabilities |
1,148.10 | 493.69 | 1,479.50 | 1,487.59 | 930.68 | 1,045.80 | 1,863.27 | 1,097.70 | 1,187.41 | 985.45 |
Total liabilities |
1,508.22 | 1,004.94 | 2,035.49 | 2,090.35 | 1,842.45 | 1,735.10 | 2,621.81 | 2,008.35 | 2,206.53 | 2,380.56 |
Additional Paid In Capital |
1,379.13 | 1,450.82 | 1,511.47 | 1,570.69 | 1,622.20 | 1,682.43 | 1,772.08 | 1,896.60 | 2,033.60 | 2,190.61 |
Common Stock (Net) |
0.57 | 0.57 | 0.58 | 0.58 | 0.58 | 0.59 | 0.59 | 0.59 | 0.76 | 0.76 |
Retained Earnings |
2,316.24 | 2,432.33 | 2,436.41 | 2,832.99 | 3,079.64 | 3,613.74 | 4,253.02 | 4,991.65 | 6,081.49 | 7,255.12 |
Treasury Stock |
1,546.61 | 1,600.41 | 1,623.26 | 1,623.26 | 1,623.26 | 1,623.26 | 1,623.26 | 1,773.27 | 2,073.29 | 2,778.59 |
Common Equity (Total) |
1,960.27 | 2,058.98 | 2,072.19 | 2,497.03 | 2,885.68 | 3,360.75 | 4,129.90 | 4,864.04 | 5,967.86 | 6,585.39 |
Shareholders Equity (Total) |
1,960.27 | 2,058.98 | 2,072.19 | 2,497.03 | 2,885.68 | 3,360.75 | 4,129.90 | 4,864.04 | 5,967.86 | 6,585.39 |
Shareholders Equity and Liabilities (Total) |
3,468.49 | 3,063.92 | 4,107.68 | 4,587.38 | 4,728.13 | 5,095.85 | 6,751.71 | 6,872.39 | 8,174.39 | 8,965.95 |
Shares (Common) |
142.18 | 142.68 | 143.66 | 144.89 | 145.65 | 146.41 | 147.06 | 146.90 | 146.39 | 144.24 |
Shareholders Equity (Tangible) |
633.59 | 774.85 | (306.21) | 158.53 | 565.20 | 1,078.37 | 807.26 | 1,536.08 | 2,456.32 | 3,223.08 |
Net Debt |
256.68 | 81.29 | 1,111.73 | 700.98 | 348.07 | 491.62 | 1,203.34 | 458.95 | (551.06) | (1,069.82) |
Total Debt |
1,078.61 | 269.99 | 1,258.86 | 1,164.13 | 643.35 | 765.33 | 1,431.23 | 697.31 | 658.39 | 399.42 |